Literature DB >> 33551563

Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type 1 Diabetes.

Andrew L Hendrickson1, Xiao Q Ye1,2, Saminder S Kalra3, Andrew J Franck1, Daniel Urbine1,3.   

Abstract

Entities:  

Year:  2021        PMID： 33551563      PMCID： PMC7839603          DOI： 10.2337/cd20-0019

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN： 0891-8929


× No keyword cloud information.
  10 in total

1.  Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.

Authors:  Jenny E Blau; Sri Harsha Tella; Simeon I Taylor; Kristina I Rother
Journal:  Diabetes Metab Res Rev       Date:  2017-09-29       Impact factor: 4.876

Review 2.  The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management.

Authors:  Ebenezer A Nyenwe; Abbas E Kitabchi
Journal:  Metabolism       Date:  2015-12-19       Impact factor: 8.694

3.  Severe anion gap metabolic acidosis associated with initiation of a very low-carbohydrate diet.

Authors:  Sijan Basnet; Niranjan Tachamo; Salik Nazir; Rashmi Dhital; Asad Jehangir; Anthony Donato
Journal:  J Community Hosp Intern Med Perspect       Date:  2019-04-12

Review 4.  Hyperglycemic crises in adult patients with diabetes.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; John M Miles; Joseph N Fisher
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

5.  Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.

Authors:  Anne L Peters; Elizabeth O Buschur; John B Buse; Pejman Cohan; Jamie C Diner; Irl B Hirsch
Journal:  Diabetes Care       Date:  2015-06-15       Impact factor: 19.112

6.  Recognizing and Appropriately Treating Latent Autoimmune Diabetes in Adults.

Authors:  Katherine S O'Neal; Jeremy L Johnson; Rebekah L Panak
Journal:  Diabetes Spectr       Date:  2016-11

Review 7.  Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols.

Authors:  Tara T T Tran; Anthony Pease; Anna J Wood; Jeffrey D Zajac; Johan Mårtensson; Rinaldo Bellomo; Elif I I Ekinci
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-13       Impact factor: 5.555

8.  Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.

Authors:  Alexis Diaz-Ramos; Wesley Eilbert; Diego Marquez
Journal:  Int J Emerg Med       Date:  2019-09-05

Review 9.  International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

Authors:  Thomas Danne; Satish Garg; Anne L Peters; John B Buse; Chantal Mathieu; Jeremy H Pettus; Charles M Alexander; Tadej Battelino; F Javier Ampudia-Blasco; Bruce W Bode; Bertrand Cariou; Kelly L Close; Paresh Dandona; Sanjoy Dutta; Ele Ferrannini; Spiros Fourlanos; George Grunberger; Simon R Heller; Robert R Henry; Martin J Kurian; Jake A Kushner; Tal Oron; Christopher G Parkin; Thomas R Pieber; Helena W Rodbard; Desmond Schatz; Jay S Skyler; William V Tamborlane; Koutaro Yokote; Moshe Phillip
Journal:  Diabetes Care       Date:  2019-02-06       Impact factor: 17.152

10.  Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors.

Authors:  Wataru Ogawa; Kazuhiko Sakaguchi
Journal:  J Diabetes Investig       Date:  2015-09-06       Impact factor: 4.232
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.